Cryo-Cell InternationalSTU:ZCY -2.52%58 Dividend Yield % is 4.25% as of Jun. 28, 2026, which is 58% below its 10-year median of 10.19. GuruFocus rates STU:ZCY with a GF Score™ of 58/100 and a GF Value™ of €6.10 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Cryo-Cell International ranks better than 86.48% on this metric.
As of today (2026-06-28), the Trailing Annual Dividend Yield of Cryo-Cell International is 4.25%.
The historical rank and industry rank for Cryo-Cell International's Dividend Yield % or its related term are showing as below:
STU:ZCY'
s Dividend Yield % Range Over the Past 10 Years
Min: 2.84 Med: 10.19 Max: 15.88
Current: 4.25
During the past 13 years, the highest Dividend Yield of Cryo-Cell International was 15.88%. The lowest was 2.84%. And the median was 10.19%.
STU:ZCY's Dividend Yield % is ranked better than 86.48% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.4
vs STU:ZCY: 4.25
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Cryo-Cell International Inc is 0.75, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Cryo-Cell International was 5.00. The lowest was 0.77. And the median was 3.47.
During the past 12 months, Cryo-Cell International's average Dividends Per Share Growth Rate was -70.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Cryo-Cell International (STU:ZCY) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:ZCY vs CDIX, EHSI, CCM: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Cryo-Cell International's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's Dividend Yield % falls into.
Cryo-Cell International (STU:ZCY) has a Dividend Yield % of 4.25% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Cryo-Cell International and its competitors. This is 58% below median its historical median of 10.19. Over the past decade, Cryo-Cell International's Dividend Yield % has ranged from 2.84 to 15.88. According to the industry distribution chart, Cryo-Cell International ranks #38 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 13.5%.
Is Cryo-Cell International's Dividend Yield % too high?
Cryo-Cell International's current Dividend Yield % of 4.25% is 58% below median its 10-year median of 10.19. Over the past 10 years, this metric has ranged from a low of 2.84 to a high of 15.88. The Healthcare Providers & Services industry median Dividend Yield % is 2.40. Cryo-Cell International's value of 4.25% is 77.1% above this industry median. Based on the distribution chart, Cryo-Cell International ranks #38 out of 281 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cryo-Cell International has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Dividend Yield % compare to CDIX and EHSI?
According to the Healthcare Providers & Services industry distribution chart, Cryo-Cell International ranks #38 out of 281 companies for Dividend Yield %. This places Cryo-Cell International in the top 14% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.40. Cryo-Cell International's value of 4.25% is 77.1% above this benchmark. Historically, Cryo-Cell International's own Dividend Yield % has ranged from 2.84 to 15.88 over the past decade. While the company's 10-year median is 10.19 vs. the industry median of 2.40, Cryo-Cell International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cryo-Cell International's current Dividend Yield % of 4.25% is 77.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Cryo-Cell International and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryo-Cell International's current Dividend Yield % is 4.25%, which is 58% below median its own 10-year median of 10.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (STU:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €6.10, compared to a current price of €3.10 — trading 49.2% below its estimated fair value. The current Dividend Yield % is 4.25%, which is 58% below median its 10-year median of 10.19 and 77.1% above the Healthcare Providers & Services industry median of 2.40. Cryo-Cell International's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Cryo-Cell International (STU:ZCY), the current Dividend Yield % is 4.25% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cryo-Cell International (STU:ZCY) Overvalued in 2026?
Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued.
The current stock price of €3.10 is trading 49.2% below its estimated GF Value™ of €6.10.
GuruFocus considers Cryo-Cell International to be Possible Value Trap.
Key valuation signals for STU:ZCY:
Dividend Yield %: 4.25% (58% below median its 10-year median of 10.19)
GF Value™: €6.10 vs. price of €3.10 (49.2% below fair value)
Industry Position: 77.1% above the Healthcare Providers & Services median (#38 of 281)
No single metric tells the full story. See the STU:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
58GF Score
Get the complete analysis for STU:ZCY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:ZCY has been successfully added to your 
